Fibrosing cholestatic hepatitis with hepatitis C virus treated by double filtration plasmapheresis and interferon plus ribavirin after liver transplantation

Clinical Journal of Gastroenterology

Volumn 2, Issue 2, 2009, Pages 125-130

  Miyake, Teruki ^a   Michitaka, Kojiro ^a   Tokumoto, Yoshio ^a   Furukawa, Shinya ^a   Ueda, Teruhisa ^a   Soga, Yoshiko ^a   Abe, Masanori ^a   Matsuura, Bunzo ^a   Nakamura, Taro ^a   Tohyama, Taiji ^a   Kobayashi, Nobuaki ^a   Hiasa, Yoichi ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholestasis; Hyperbilirubinemia; Hyperviremia; Liver failure

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; BETA INTERFERON; BILIRUBIN; CORTICOSTEROID; CYCLOSPORIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; STEROID; TACROLIMUS;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTATIC HEPATITIS; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS C VIRUS; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 77953411629     PISSN: 18657257     EISSN: 18657265     Source Type: Journal    
DOI: 10.1007/s12328-008-0057-5     Document Type: Article

References (28)

1. M Berenguer J Crippin R Gish N Bass A Bostrom G Netto 2003 A model to predict severe HCV-related disease following liver transplantation Hepatology 38 34 41 (Pubitemid 36775793)
2. E Gane 2003 The natural history and outcome of liver transplantation in hepatitis C-virus infected recipients Liver Transpl 9 28 34 (Pubitemid 37408000)
3. RH Wiesner M Sorrell F Villamil 2003 Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C Liver Transpl 9 1 9 (Pubitemid 37407996)
4. N Singh T Gayowski CF Wannstedt AO Shakil MM Wagener JJ Fung 1998 Interferon alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients Transplantation 65 82 86
5. PA Sheiner P Boros FM Klion SN Thung LK Schluger JY Lau 1998 The efficacy of prophylactic interferon alpha 2b in preventing recurrent hepatitis C after liver transplantation Hepatology 28 831 838 (Pubitemid 28405437)
6. P Toniutto C Fabris E Fumo L Apollonio M Caldato C Avellini 2005 Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: comparison of tolerability and efficacy J Gastroenterol Hepatol 20 577 582 (Pubitemid 40755270)
7. GW Neff M Montalbano CB O'Brien S Nishida K Safdar PA Bejarano 2004 Treatment of established recurrent hepatitis C in liver-transplant reciepents with pegylated interferon-alfa-2b and ribavirin therapy Transplantation 78 1303 1307 (Pubitemid 39507968)
8. H Rodriguez-Luna A Khatib P Sharma G De Petris JW Williams J Ortiz 2004 Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series Transplantation 77 190 194 (Pubitemid 38155744)
9. LK Schluger PA Sheiner SN Thung JY Lau A Min DC Wolf 1996 Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation Hepatology 23 971 976 (Pubitemid 26137034)
10. RC Dickson SH Caldwell MB Ishitani JY Lau CJ Driscoll WC Stevenson 1996 Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation Transplantation 61 701 705 (Pubitemid 26097228)
11. H Zylberberg F Carnot MF Mamzer G Blancho C Legendre S Pol 1997 Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation Transplantation 63 158 160 (Pubitemid 27036708)
12. HL Lim GK Lau GL Davis DJ Dolson JY Lau 1994 Cholestatic hepatitis leading to hepatic failure in a patient with organ transmitted hepatitis C virus infection Gastroenterology 106 248 251 (Pubitemid 24011889)
13. LR Dixon JM Crawford 2007 Early histologic changes in fibrosing cholestatic hepatitis C Liver Transpl 13 219 226 (Pubitemid 46351647)
14. DV Gopal HR Rosen 2003 Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite Liver Transpl 9 348 353 (Pubitemid 36443045)
15. A Kornberg B Küpper A Tannapfel K Thrum E Bärthel U Settmacher 2006 Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology Liver Int 26 811 816 (Pubitemid 44165248)
16. M Kaito S Watanabe K Tsukiyama-Kohara K Yamaguchi Y Kobayashi M Konishi 1994 Hepatitis C virus particle detected by immunoelectron microscopic study J Gen Virol 75 1755 1760 (Pubitemid 24211260)
17. K Fujiwara S Kaneko M Sata S Hige E Tomita S Mochida 2007 The Virus Reduction Therapy Study Group. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load Hepatol Res 37 701 710 (Pubitemid 47054776)
18. T Yamashita K Arai A Sakai E Mizukoshi Y Sakai T Kagaya 2006 Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: a preliminary study Hepatol Res 36 167 175 (Pubitemid 44575935)
19. JP Ong ZM Younossi T Gramlich Z Goodman J Mayes S Sarbah 2000 Interferon α 2B and ribavirin in severe recurrent cholestatic hepatitis C Transplantation 10 1486 1488
20. T tmp McCashland K Watt E Lyden L Adams M Charlton AD Smith 2007 Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study Liver Transpl 13 1246 1253 (Pubitemid 47457051)
21. SE Davies BC Portmann JG O'Grady PM Aldis K Chaggar GJ Alexander 1991 Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 13 150 157
22. SA Zanati SA Locarnini JP Dowling PW Angus FJ Dudley SK Roberts 2004 Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine J Clin Virol 31 53 57 (Pubitemid 39024385)
23. N Waguri T Ichida R Fujimaki T Ishikawa M Nomoto H Asakura 1998 Fibrosing cholestatic hepatitis after living related-donor renal transplantation J Gastroenterol Hepatol 13 1133 1137 (Pubitemid 28529855)
24. MG Pessoa N Bzowej M Berenguer Y Phung M Kim L Ferrell 1999 Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation Hepatology 30 1513 1520
25. A Manzin M Candela L Solforosi A Gabrielli M Clementi 1999 Dynamics of hepatitis C viremia after plasma exchange J Hepatol 31 389 393 (Pubitemid 29408718)
26. V Schettler M Monazahian E Wieland G Ramadori RW Grunewald R Thomssen 2001 Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis Eur J Clin Invest 31 154 155 (Pubitemid 32201195)
27. V Schettler M Monazahian E Wieland R Thomssen GA Muller 2001 Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load Ther Apher 5 384 386 (Pubitemid 34036534)
28. M Taniguchi H Furukawa T Shimamura T Suzuki K Yamashita M Ota 2006 Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C Transplantation 81 1747 1749 (Pubitemid 43948311)